Kristian Løkke Funck (K L Funck, Kristian L Funck)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Cardiovascular Disease

Computed Tomography

Top Venues

Diabetes, obesity & metabolism

Diabetic medicine : a journal of the British Diabetic Association

Diabetes & vascular disease research

This page only lists publications with an associated author ORCID identifier.

Publications

Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian Løkke Funck, Per Løgstrup Poulsen, Esben Laugesen
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia (2024)
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Kristian Løkke Funck, Esben Laugesen, Per L Poulsen
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial. Diabetes, obesity & metabolism 26 (5) (2024)
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Kristian Løkke Funck, Esben Laugesen, Per L Poulsen
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial. Diabetes, obesity & metabolism (2024)
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Kristian Løkke Funck, Esben Laugesen, Per L Poulsen
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial. Diabetes, obesity & metabolism 26 (5) (2024)
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Henrik Birn, Kristian Løkke Funck, Esben Laugesen, Per Løgstrup Poulsen
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial. Diabetologia (2024)
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian Løkke Funck, Per Løgstrup Poulsen, Esben Laugesen
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia (2023)
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian Løkke Funck, Per Løgstrup Poulsen, Esben Laugesen
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia 66 (5) (2023)
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian Løkke Funck, Per Løgstrup Poulsen, Esben Laugesen
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia 66 (5) (2023)
Kristian Løkke Funck, Esben Laugesen, Pernille Høyem, Brian Stausbøl-Grøn, Won Y Kim, Leif Østergaard, Dora Grauballe, Troels K Hansen, Christian S Buhl, Per L Poulsen
Arterial stiffness and progression of cerebral white matter hyperintensities in patients with type 2 diabetes and matched controls: a 5-year cohort study. Diabetology & metabolic syndrome 13 (1) (2021)
Kristian Løkke Funck, Ricardo P J Budde, Mette H Viuff, Jan Wen, Jesper M Jensen, Bjarne L Nørgaard, Lidia R Bons, Anthonie L Duijnhouwer, Damini Dey, Kristian H Mortensen, Niels H Andersen, Jolien W Roos-Hesselink, Claus H Gravholt
Coronary plaque burden in Turner syndrome a coronary computed tomography angiography study. Heart and vessels 36 (1) (2020)
Kristian Løkke Funck, Jakob Schöllhammer Knudsen, Troels Krarup Hansen, Reimar Wernich Thomsen, Erik Lerkevang Grove
Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019. Diabetes, obesity & metabolism 23 (2) (2020)
Liv Vernstrøm, E Laugesen, E L Grove, J M Baier, S Gullaksen, A-M Hvas, P L Poulsen, Kristian Løkke Funck
Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetes. Diabetic medicine : a journal of the British Diabetic Association 36 (9) (2019)
Søren Gullaksen, Kristian Løkke Funck, Esben Laugesen, Troels Krarup Hansen, Damini Dey, Per Løgstrup Poulsen
Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls. Diabetes & vascular disease research 16 (4) (2019)